No Business, No Medicine - ft. Nadav Askari Ph.D.

Why don’t companies just give life-saving drugs away for free?Because a breakthrough in a lab doesn’t save lives. Delivery does — and delivery is brutally expensive.Nadav Askari Ph.D. is a biotech executive specializing in translating scientific discoveries into real-world medical products, working at the intersection of research, patents, and commercialization.Turning an idea into an actual medicine can take 10–15 years, thousands of failed experiments, massive clinical trials, and billions of dollars on the line. And there is no such thing as a worldwide patent — protection must be secured country by country.Without exclusivity, there would be little reason for anyone to take that risk.Here’s the uncomfortable reality: many of the people who bring treatments to market didn’t invent the science. They validated it, funded it, navigated regulation, and survived the longest and most expensive process in modern innovation.Science discovers.Business delivers.Patients live somewhere in between.When science meets business, ethics, money, and survival collide.If you want conversations that go beyond headlines and challenge what you think you know, subscribe and join the discussion.Suscribe to:  @verdadesincomodas_ok  Produces:  @ecosdelegeo ​